Jet Brinkman

Van Lanschot Kempen Investment Management NV (Van Lanschot Kempen) is a specialist wealth manager headquartered in Amsterdam, Netherlands. The firm was founded in 1991 and was formerly known as Kempen Capital Management NV. They are a wholly-owned subsidiary of Van Lanschot Kempen NV (AMS: VLK). Van Lanschot Kempen administers Dutch pension funds and provides integral asset management for Dutch institutional clients.

LSP Management Group BV (LSP) is an independent European venture capital firm which was founded by Martijn Kleijwegt, Frits van der Have and Tom Schwarz in 1998. Headquartered in Amsterdam, the firm provides financing to early- to mid-stage life science companies.

Gimv Nederland BV (Gimv-Nederland) is the Netherlands-based private equity subsidiary of GIMV Corporate Investment, which in turn is a subsidiary of Gimv NV (XB: GIMB) in Belgium. Established in 1983, Gimv-Nederland was formerly known as Halder Invest BV and became part of the Gimv Group in 2000. The firm is located in The Hague with additional offices in Frankfurt and Antwerp. Their clients include fund of funds, insurance companies, banks, corporations and pension funds.

Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies.

Rivean Capital BV (Rivean Capital) is a private equity subsidiary of Rivean Capital Management Holding BV founded in 1982. The firm is headquartered in Amsterdam, the Netherlands.

Ontwikkelingsmaatschappij Oost Nederland NV (Development Agency East Netherlands) is an Independent Private Equity/Venture Capital firm that focuses its activities on strengthening the economy of the provinces of Gelderland and Overijssel, the Netherlands. Oost NV is headquartered in Apeldoorn.

AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands.

Agrifirm Group BV owns and operates a network of petrol stations. It sells fuel to motorists with a chain of unmanned service stations. The company was founded in 2000 and is headquartered in Rotterdam, the Netherlands.

InteRNA Technologies BV develops RNA technologies and applications. It provides drug discovery and development services for the treatment of cancer based on the proprietary microRNA (miRNA) functions. The company develops miRNA-based therapeutics that control genes connected in signal transduction pathways and biological processes as a part of cancer initiation, progression and metastasis. InteRNA Technologies was founded by Edwin Cuppen and Eugene Berezikov in December 2006 and is headquartered in Nijmegen, the Netherlands.

Vendis Management BVBA (Vendis Capital) is an independent private equity firm that was founded by Michiel Deturck, Cedric Olbrechts, Luc Geuten and Willem Van Aelten in 2009. The firm is headquartered in Diegem, Belgium.

Mauritsklinieken Holding BV deals with the dermatology services. It specializes in cosmetology, skin therapy, miraDry, and varicose veins. The company was founded by Corne Otto in 2004 and is headquartered in The Hague, The Netherlands.

Opdidakt BV operates learning and development research institutions. It offers dyslexia guidance, remedial teaching, first and second line psychology, socio-emotional support, and homework supervision services. The company is headquartered in 's-Hertogenbosch, the Netherlands.

Eshgro BV provides information and communications technology services. It offers online desktop, telephony and printing services. The firm hosts and manages office automatisation, client and branch specific solutions on its multi-enterprise platform. The company was founded by Anton Loeffen in 1997 and is headquartered in Boxmeer, the Netherlands.

Amolyt Pharma SAS engages in development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases. The company was founded by Thierry Abribat in 2014 and is headquartered in Ecully, France.

Livassured BV develops monitoring devices for epilepsy patients that identifies nocturnal seizures. The company was founded by Mark Bloemendaal and Asmund Tielens and is headquartered in Vught, the Netherlands.

Part of Akzo Nobel NV, Akzo Nobel Car Refinishes, Inc. is a company that manufactures and supplies paints and services to car repair and commercial vehicles. The company is based in Norcross, GA.

Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom.

Redmedtech Discovery Fund is an independent private equity firm with its headquarters in Apeldoorn, the Netherlands. It was founded in 2014.

Part of British American Tobacco plc, PT Bentoel Internasional Investama is an Indonesian company that manufactures and supplies cigarettes. The company is based in Jakarta, Indonesia.

Victus Participations BV is an Independent Private Equity firm founded in 2017. Victus Participations BV is headquartered in Amsterdam.

Amphista Therapeutics Ltd. is a biopharmaceutical company based in Biocity Glasgow, UK. The British company is focused on creating first-in-class therapeutics that selectively and efficiently degrade and remove disease-causing proteins using targeted protein degradation (TPD). The company's pipeline of novel small molecules is focused on challenging diseases, including cancer. Amphista is a spin-out of Professor Alessio Ciulli's labs at the University of Dundee and is funded by leading life science investors, including Advent Life Sciences, the European Investment Fund, the Scottish Investment Bank, and Biomotiv. The CEO of the company is Nicola Thompson.

Ice Lake Capital Management BV (IceLake Capital) is a private equity firm founded in 2018 by Bastiaan Hagenouw, Matteo Racca and Vincent Lüning. The firm is headquartered in Amsterdam, the Netherlands.

Vico Therapeutics BV is a private biotech company based in Leiden, Netherlands that focuses on developing RNA modulating therapies for rare severe neurological disorders. The Dutch company's antisense oligonucleotide platform (AON) is directed towards different forms of spinocerebellar ataxia (SCA) and Huntington disease (HD), while its early discovery RNA editing platform is directed towards Rett syndrome. Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Gail Mandel, and Dr. Judith van Deutekom, who have strong academic reputations and vast industry experience. Micah Mackison has been the CEO of the company since 2022.

Sirius Medical BV engages in medical industry. The firm focuses on developing medical devices for oncological surgery. The company was founded by Hubert Martens and Bram Schermers and is headquartered in Eindhoven, the Netherlands.

BV HealthConnected is a healthcare platform that aims to improve the quality of care by using ICT. The company is based in Alkmaar, Netherlands, and has a clear vision of how ICT can improve healthcare. The platform connects thousands of care providers and millions of patients, and it is designed for primary care, network care, and the entire region. The Dutch company values information security and has a flexible CISO. The company also has an e-learning application and share their success stories and knowledge on various topics through their publications. BV HealthConnected offers vacancies for those who want to contribute to society. Paul Witteman has been the CEO of the company since 2018.

Part of Netherlands Foreign Investment Agency, the Dutch company provides investment advisory services.

Evommune, Inc. engages in the development of medicines for inflammatory diseases. The company was founded by Luis C. Pe?a, Eugene Andrew Bauer, and Hans Hofland in 2020 and is headquartered in Los Altos, CA.

Egle Therapeutics SAS is a biotech company based in Paris, France. Egle Therapeutics develops first-in-class immunotherapies targeting immune suppressor regulatory T cells (Tregs) for oncology and autoimmune diseases. The French company leverages its translational-based target discovery platform to unveil novel therapeutic Treg targets and computationally designed immunocytokines acting as antagonists or as selective Treg-agonists. The company was founded in 2020 by Luc Boblet, a serial biotech entrepreneur, and Dr. Eliane Piaggio, a renowned immunologist.

EQT Life Sciences Group BV (EQT Life Sciences) is a venture capital firm, a subsidiary of EQT AB founded in 2022 after the acquisition of LSP by EQT. The firm is headquartered in Amsterdam, the Netherlands.

Xilloc Medical Int BV is a Dutch company that manufactures medical instruments, implants, and anatomical models. The company is based in Sittard-Geleen, the Netherlands, and has subsidiaries in the Netherlands. The company was founded in 2003 by Maikel Beerens, and the CEO is Milko Wijckmans.